Design of siRNA Therapeutics from the Molecular Scale
While protein-based therapeutics is well-established in the market, development of nucleic acid therapeutics has lagged. Short interfering RNAs (siRNAs) represent an exciting new direction for the pharmaceutical industry. These small, chemically synthesized RNAs can knock down the expression of targ...
Saved in:
Main Authors: | Christina Chan (Author), S. Patrick Walton (Author), Daniel Vocelle (Author), Phillip Angart (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2013-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Delivery of siRNA Therapeutics
Published: (2020) -
Drug Delivery of siRNA Therapeutics
by: Gaetano Lamberti, et al.
Published: (2020) -
siRNA Therapeutics: From Bench Lab. to Clinics
by: Cristina Romero-López, et al.
Published: (2024) -
Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA
by: Maria Abdul Ghafoor Raja, et al.
Published: (2019) -
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
by: Muhammad Imran Sajid, et al.
Published: (2020)